MYC and cancer: Our data suggest a crosstalk of NMU signaling with several cancer-relevant pathways including the WNT receptor cascade resulting in an increased activation of the WNT/PCP effector RAC1 as an indicator for enhanced cancer cell motility and down-regulation of the canonical WNT target MYC among others.